cbdMD Inc
YCBD0.935USD
+0.075+8.72%
Close 05/09, 16:00（ET）Quotes delayed by 15 min
5.18MMarket Cap
LossP/E TTM
More Details of cbdMD Inc Company
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Company Info
Company codeYCBD
Company namecbdMD Inc
IPO dateNov 17, 2017
Founded at2015
CEOMr. T. Ronan Kennedy
Number of employees42
Security typeOrdinary Share
Fiscal year-endNov 17
Address8845 Red Oak Blvd
CityCHARLOTTE
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code28217-5593
Phone17044453060
Websitehttps://www.cbdmd.com/
Company codeYCBD
IPO dateNov 17, 2017
Founded at2015
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
656.00
+23.54%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
549.00
+29.48%
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
656.00
+23.54%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
549.00
+29.48%
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
By BusinessUSD
Name
Revenue
Proportion
E-commerce sales
3.95M
77.30%
Wholesale sales
1.16M
22.70%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
E-commerce sales
3.95M
77.30%
Wholesale sales
1.16M
22.70%
Shareholder
Update time: Sat, May 10
Update time: Sat, May 10
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Porter (Jeffrey H)
0.80%
Coffman (Raymond Scott)
0.54%
Lambeth (Marianne)
0.52%
Connective Capital Management, LLC
0.13%
Raines (William F III)
0.11%
Other
97.89%
Shareholder Statistics
Shareholder
Proportion
Porter (Jeffrey H)
0.80%
Coffman (Raymond Scott)
0.54%
Lambeth (Marianne)
0.52%
Connective Capital Management, LLC
0.13%
Raines (William F III)
0.11%
Other
97.89%
Type
Shareholder
Proportion
Individual Investor
2.02%
Hedge Fund
0.19%
Research Firm
0.06%
Investment Advisor/Hedge Fund
0.03%
Venture Capital
0.02%
Investment Advisor
0.01%
Other
97.66%
Institutional Shareholding
Update time: Wed, Mar 5
Update time: Wed, Mar 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
79
136.53K
1.53%
-32.92K
2024Q4
76
811.68K
23.02%
+42.15K
2024Q3
80
869.63K
30.51%
+134.84K
2024Q2
85
734.40K
27.03%
-50.91K
2024Q1
91
757.62K
28.39%
-18.50K
2023Q4
95
764.16K
29.72%
+83.63K
2023Q3
108
684.81K
27.23%
+10.72K
2023Q2
117
634.68K
40.66%
-58.78K
2023Q1
120
655.15K
47.20%
-12.99K
2022Q4
124
560.94K
41.64%
-98.77K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Coffman (Raymond Scott)
387.69K
6.19%
--
--
Feb 21, 2025
Lambeth (Marianne)
373.60K
5.97%
--
--
Feb 21, 2025
Connective Capital Management, LLC
89.22K
1.42%
--
--
Dec 31, 2024
Raines (William F III)
81.42K
1.3%
+1.00K
+1.24%
Feb 21, 2025
Virtu Americas LLC
45.65K
0.73%
+45.65K
--
Dec 31, 2024
Two Sigma Investments, LP
16.11K
0.26%
-5.95K
-26.98%
Dec 31, 2024
The Vanguard Group, Inc.
13.04K
0.21%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
11.20K
0.18%
--
--
Dec 31, 2024
View more
Related ETFs
Update time: Tue, May 6
Update time: Tue, May 6
Name
Proportion
AdvisorShares Pure Cannabis ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Amplify Seymour Cannabis ETF
0%
Cambria Cannabis ETF
0%
AdvisorShares Pure Cannabis ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Amplify Seymour Cannabis ETF
Proportion0%
Cambria Cannabis ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1
Date
Type
Ratio
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1